Because JUUL’s products continue to have the largest share of the e-cigarette market, and therefore presumably are undergoing expedited review, we write at this time to express our conclusion that based on all of the publicly available evidence, no JUUL product currently on the market can meet the statutory public health standard. Therefore, they should not receive a marketing order.
FDA Regulation of Tobacco Products: Modified Risk Tobacco Products
December 11, 2020
This factsheet provides a summary of the modified risk tobacco producat application process at FDA and ACS CAN's position.